Literature DB >> 19385726

Resurrected pandemic influenza viruses.

Terrence M Tumpey1, Jessica A Belser.   

Abstract

Influenza viruses continue to pose a major global public health problem. There is a need to better understand the pathogenicity and transmission of pandemic influenza viruses so that we may develop improved methods for their prevention and control. Reconstruction of the 1918 virus and studies elucidating the exceptional virulence and transmissibility of the virus are providing exciting new insights into this devastating pandemic strain. The primary approach has been to reconstruct and analyze recombinant viruses, in which genes of the 1918 virus are replaced with genes of contemporary influenza viruses of lesser virulence. This review highlights the current status of the field and discusses the molecular determinants of the 1918 pandemic virus that may have contributed to its virulence and spread. Identifying the exact genes responsible for the high virulence of the 1918 virus will be an important step toward understanding virulent influenza strains and will allow the world to better prepare for and respond to future influenza pandemics.

Mesh:

Substances:

Year:  2009        PMID: 19385726     DOI: 10.1146/annurev.micro.091208.073359

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  19 in total

1.  Ferretting out the facts behind the H5N1 controversy.

Authors:  Roy D Sleator
Journal:  Bioeng Bugs       Date:  2012-05-01

2.  Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus.

Authors:  Benjamin Mänz; Veronika Götz; Kerstin Wunderlich; Jessica Eisel; Johannes Kirchmair; Jürgen Stech; Olga Stech; Geoffrey Chase; Ronald Frank; Martin Schwemmle
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

3.  Avian H5N1 influenza: In or out flew-enza?

Authors:  John G Morgan
Journal:  Bioeng Bugs       Date:  2012-05-01

4.  Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.

Authors:  Moon Cheol Kang; Dong-Hoon Choi; Young Woo Choi; Seong Jeong Park; Hong Namkoong; Ki Seok Park; So-Shin Ahn; Charles D Surh; Sun-Woo Yoon; Doo-Jin Kim; Jung-ah Choi; Yunji Park; Young Chul Sung; Seung-Woo Lee
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

5.  Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.

Authors:  Yufeng Song; Xiang Wang; Hongbo Zhang; Xinying Tang; Min Li; Jufang Yao; Xia Jin; Hildegund C J Ertl; Dongming Zhou
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

6.  Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.

Authors:  Chunfeng Li; Zining Wang; Yang Cao; Lulan Wang; Jingyun Ji; Zhigao Chen; Tao Deng; Taijiao Jiang; Genhong Cheng; F Xiao-Feng Qin
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

7.  Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12.

Authors:  Brian S Hamilton; Gary R Whittaker
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

8.  Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.

Authors:  Taronna R Maines; Akila Jayaraman; Jessica A Belser; Debra A Wadford; Claudia Pappas; Hui Zeng; Kortney M Gustin; Melissa B Pearce; Karthik Viswanathan; Zachary H Shriver; Rahul Raman; Nancy J Cox; Ram Sasisekharan; Jacqueline M Katz; Terrence M Tumpey
Journal:  Science       Date:  2009-07-02       Impact factor: 47.728

9.  Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.

Authors:  Kerstin Wunderlich; Daniel Mayer; Charlene Ranadheera; Anne-Sophie Holler; Benjamin Mänz; Arnold Martin; Geoffrey Chase; Werner Tegge; Ronald Frank; Ulrich Kessler; Martin Schwemmle
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

10.  Human genomics and preparedness for infectious threats.

Authors:  Nicole F Dowling; Marta Gwinn; Alison Mawle
Journal:  Genome Med       Date:  2009-12-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.